The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Carl L. G. Hansen net worth and biography

Carl Hansen Biography and Net Worth

CEO of AbCellera Biologics

Carl Hansen is AbCellera’s founding CEO. Until August 2019, Carl was a Professor at the University of British Columbia, where he co-authored over 65 manuscripts in the fields of microfluidics, immunology, genomics, and nanotechnology. He is an inventor of over 50 US patents and 63 US patent applications that are represented in 7 commercial products. He received the Michael Smith Career investigator award and was recently named one of the “Top 5 Canadian CEOs who elevate their companies.” Carl received his PhD in Applied Physics/Biotechnology from Caltech, and a BASc in Engineering Physics and Honors Mathematics from the University of British Columbia. Before leading AbCellera, he was a scientific Co-Founder of Precision Nanosystems, a Vancouver-based company developing next-generation delivery technology for genetic medicines, and served on the SAB of Fluidigm Corp.

How old is Carl L. G. Hansen?: Dr. Hansen is currently 49 years old. There are 4 older executives and no younger executives at AbCellera Biologics. The oldest executive at AbCellera Biologics is Mr. Tryn T. Stimart Esq., J.D., M.Sc., Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer, who is 54 years old. Learn More on Carl L. G. Hansen's age.
How do I contact Carl L. G. Hansen?: The corporate mailing address for Dr. Hansen and other AbCellera Biologics executives is , , . AbCellera Biologics can also be reached via phone at 604-559-9005 and via email at [email protected]. Learn More on Carl L. G. Hansen's contact information.
Has Carl L. G. Hansen been buying or selling shares of AbCellera Biologics?: Carl L. G. Hansen has not been actively trading shares of AbCellera Biologics in the last ninety days. Most recently, Carl L. G. Hansen sold 6,000,000 shares of the business's stock in a transaction on Wednesday, June 9th. The shares were sold at an average price of $24.13, for a transaction totalling $144,780,000.00. Learn More on Carl L. G. Hansen's trading history.
Who are AbCellera Biologics' active insiders?: AbCellera Biologics' insider roster includes Andrew Booth (CFO), John Hamer (Director), Carl Hansen (CEO), Michael Hayden (Director), Veronique Lecault (COO), Andrew Lo (Director), and John Montalbano (Director). Learn More on AbCellera Biologics' active insiders.

Carl L. G. Hansen Insider Trading History at AbCellera Biologics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/9/2021	Sell	6,000,000	$24.13	$144,780,000.00

Carl L. G. Hansen Buying and Selling Activity at AbCellera Biologics

AbCellera Biologics Company Overview

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $2.85

$2.68

$2.88

50 Day Range

MA: $2.82

$2.52

$3.15

2 Week Range

Now: $2.85

$2.34

$6.05

Volume

2,074,423 shs

Average Volume

1,770,256 shs

Market Capitalization

$841.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Vladimir Lenin was right…

From Porter & Company | Ad